Context: Coronary collateral (CC) vessel development appears to be protective with regard to adverse cardiovascular events and survival in patients with coronary chronic total occlusion (CTO). The influence of type 2 diabetes mellitus (T2DM) on CC growth has been controversial. In particular, the role of diabetic microvascular complications (DMC) in determining coronary collateralization has not been elucidated. Objective: To investigate whether patients with DMC presented differences in CC vessel presence and grading as compared with patients without DMC. Methods: We conducted a single-center observational study, including consecutive T2DM patients, without previous cardiovascular history, undergoing a clinically indicated coronary angiography for chronic coronary syndrome (CCS) and angiographic evidence of at least one CTO. Patients were subdivided into 2 study groups according to the presence/absence of at least one DMC (neuropathy, nephropathy, or retinopathy). The presence and grading of angiographically visible CC development from the patent vessels to the occluded artery were assessed using the Rentrop classification. Results: We enrolled 157 patients (mean age 68.6 ± 9.8 years; 120 [76.4%] men). Patients with DMC (75 [47.8%]) had a higher prevalence of CC (69 [92.0%] vs 62 [75.6%], P = .006) and high-grade CC (55 [73.3%] vs 39 [47.6%], P = .001) compared with those without, and we found a positive association between the number of DMC in each patient and the prevalence of high-grade CC. Conclusion: Among T2DM patients with coronary CTO, the presence of DMC was associated with a high CC development.

Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion / Gurgoglione, F. L.; Pitocco, D.; Montone, R. A.; Rinaldi, R.; Bonadonna, R. C.; Magnani, G.; Calvieri, C.; Solinas, E.; Rizzi, A.; Tartaglione, L.; Flex, A.; Viti, L.; Trani, C.; Ardissino, D.; Crea, F.; Niccoli, G.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 109:1(2024), pp. 237-244. [10.1210/clinem/dgad396]

Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion

Gurgoglione F. L.;Bonadonna R. C.;Solinas E.;Ardissino D.;Niccoli G.
2024-01-01

Abstract

Context: Coronary collateral (CC) vessel development appears to be protective with regard to adverse cardiovascular events and survival in patients with coronary chronic total occlusion (CTO). The influence of type 2 diabetes mellitus (T2DM) on CC growth has been controversial. In particular, the role of diabetic microvascular complications (DMC) in determining coronary collateralization has not been elucidated. Objective: To investigate whether patients with DMC presented differences in CC vessel presence and grading as compared with patients without DMC. Methods: We conducted a single-center observational study, including consecutive T2DM patients, without previous cardiovascular history, undergoing a clinically indicated coronary angiography for chronic coronary syndrome (CCS) and angiographic evidence of at least one CTO. Patients were subdivided into 2 study groups according to the presence/absence of at least one DMC (neuropathy, nephropathy, or retinopathy). The presence and grading of angiographically visible CC development from the patent vessels to the occluded artery were assessed using the Rentrop classification. Results: We enrolled 157 patients (mean age 68.6 ± 9.8 years; 120 [76.4%] men). Patients with DMC (75 [47.8%]) had a higher prevalence of CC (69 [92.0%] vs 62 [75.6%], P = .006) and high-grade CC (55 [73.3%] vs 39 [47.6%], P = .001) compared with those without, and we found a positive association between the number of DMC in each patient and the prevalence of high-grade CC. Conclusion: Among T2DM patients with coronary CTO, the presence of DMC was associated with a high CC development.
2024
Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion / Gurgoglione, F. L.; Pitocco, D.; Montone, R. A.; Rinaldi, R.; Bonadonna, R. C.; Magnani, G.; Calvieri, C.; Solinas, E.; Rizzi, A.; Tartaglione, L.; Flex, A.; Viti, L.; Trani, C.; Ardissino, D.; Crea, F.; Niccoli, G.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 109:1(2024), pp. 237-244. [10.1210/clinem/dgad396]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2985373
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact